COMP <GO>
DLB vs RTX // ALTMAN Z-SCORE & DEBT/EQUITY
Dolby Laboratories (NYSE) VS. RTX Corporation (NYSE) • 15-METRIC TALLY: DLB 10
— RTX 5
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: DLB
LAST: $61.99 (-1.46%) • MKT CAP: $5.89B
balance-sheet
8.20
LAST: $199.80 (+0.20%) • MKT CAP: $269.08B
balance-sheet
2.73
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (DLB VS. RTX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | DLB | RTX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 88.10% | 41.00% | +47.10 | DLB | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.50% | 7.20% | +2.30 | DLB | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.6x | 26.5x | -7.90 | DLB | /valuation <GO> |
| Free Cash Flow Yield | 7.40% | 2.95% | +4.45 | DLB | /fcf-yield <GO> |
| Operating Margin | 19.60% | 10.50% | +9.10 | DLB | /operating-margins <GO> |
| Net Profit Margin | 18.90% | 7.60% | +11.30 | DLB | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 9.70% | -3.80 | RTX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.15% | 1.33% | +0.82 | DLB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 8.20 | 2.73 | +5.47 | DLB | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 9/9 | -1.00 | RTX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.60% | +0.30 | RTX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 60.8 | -5.15 | RTX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.92 | +0.08 | DLB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.5x | 37.2x | -15.70 | DLB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.89B | $269.08B | -$263.19B | RTX | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | DLB REV | RTX REV | DLB GROSS % | RTX GROSS % | DLB FCF | RTX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.35B | $88.60B | 88.1% | 44.0% | $435.9M | $7.94B |
| FY 2024 | $1.27B | $80.74B | 89.0% | 44.0% | $297.2M | $4.53B |
| FY 2023 | $1.30B | $68.92B | 44.0% | 44.0% | $308.6M | $4.78B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
DLB // BETA 1.00
RTX // BETA 0.92